A Study of LY2523355 in Participants With Breast Cancer
PHASE2
The purpose of the study is to evaluate the anti-tumor activity of LY252335...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy
PHASE3
This phase III, multicenter, randomized, open-label trial evaluates whether...